Asahi Songwon consolidated PAT jumps 6x YoY on margin recovery; eases QoQ from Q1 high
PAT +609.96% YoY · revenue +66.56% · margins expanding
₹201.36 Cr
+66.56% YoY
₹14.89 Cr
+609.96% YoY
7.32%
+5.6pp YoY
₹12.78
Asahi Songwon's consolidated PAT (basis: consolidated, primary) came in at ₹14.89 Cr on revenue of ₹201.36 Cr for Q2 FY27 — revenue up 66.6% YoY and PAT up roughly 610% YoY against a depressed ₹2.10 Cr year-ago base, confirming the YoY recovery story flagged in the board's own Q2 note ("consolidated PAT up sharply YoY as pigments margins recover, revenue +67%"). Sequentially, growth cooled: revenue rose just 6.6% QoQ while PAT fell 21.7% QoQ from Q1 FY27's ₹19.03 Cr, so the quarter is a continuation of the YoY turnaround rather than a fresh acceleration.
Q2 FY-2027 vs prior quarters
The margin bridge explains the divergence: consolidated OPM (EBITDA/revenue) expanded to 12.31% from 7.85% a year ago, but compressed from Q1's 16.84% peak; NPM followed the same pattern, 7.32% vs 1.71% YoY but down from Q1's 10.03%. Segment data shows the API business delivered ₹1.28 Cr PBT this quarter — its third straight profitable quarter, though down from ₹4.85 Cr in Q1 — consistent with, and arguably ahead of, management's prior-concall guidance that API would reach PBT break-even "this year." Standalone (parent-only) PAT grew a smaller 327% YoY to ₹15.47 Cr, versus the consolidated group's ~610%; the gap traces to a weak year-ago subsidiary performance (Q2 FY26 consolidated PBT of ₹3.61 Cr was actually below the standalone PBT of ₹5.12 Cr that quarter, implying a subsidiary drag that has since reversed) — readers comparing the two bases should not read this as an error.
The stock went into the print at ₹387.15, up 0.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
No exceptional items disclosed — results are unaudited, subject to statutory auditors' limited review
Management anticipates continued strong performance in Q1FY27, aiming to maintain or improve upon Q4 FY26 EBITDA margins across all segments. For the Blue business, the focus is on sustainable margins at current levels and above, with a goal of reaching peak potential of approximately Rs. 50-55 crores EBITDA. The API s
— This quarter: met
No formal street consensus could be found for this print; coverage trackers (Simply Wall St, TipRanks) show only two analysts following the stock with no submitted revenue/profit estimates, so vsStreet is marked unknown rather than guessed. Against management's own prior framing — maintaining/improving FY26 margins, API and AZO reaching PBT break-even this year, and a multi-year path to ₹1,000 Cr consolidated revenue — the quarter is broadly on track: OPM of 12.31% remains well above FY26's full-year ~9.3% average even after the QoQ pullback, and API's segment profitability supports the break-even claim, though AZO/Blue-specific EBITDA figures are not broken out at the segment level this quarter so cannot be independently verified. No management press release or commentary accompanied the filing beyond the standard board-outcome letter. The quarter's other corporate actions (15% final FY26 dividend record date, AGM, insider-trading window closure) were routine and not tied to this result.
W1
API segment PBT trajectory toward full-year break-even guidance — watch if it holds above ~₹1 Cr/quarter after easing from ₹4.85 Cr (Q1) to ₹1.28 Cr (Q2)
W2
Consolidated OPM direction — whether Q3 FY27 holds near the current ~12% level or reverts further toward FY26's ~9.3% full-year average, after cooling from Q1's 16.84% peak
W3
Progress toward management's multi-year ₹1,000 Cr consolidated revenue target — H1 FY27 annualized pace (~₹780 Cr) vs FY26 actual (₹535.48 Cr)
Clear digital SEBI filing, columns unambiguous, both ties (totalIncome and PBT-tax=PAT) exact to the paisa; PAT/EPS fields use the 'Profit for the period' P&L line (pre-NCI split) — owners' share was ₹15.07 Cr vs ₹14.89 Cr total consolidated; no exceptional items disclosed in either period.